Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Afqlir 40 mg/ml Solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
aflibercept
Company:  
Sandoz Limited See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials Letters to HCPs Audio/Video
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Afqlir HCP letter

{healthcare_pro_orange} For Healthcare Professionals

Dear HCP letter

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Sandoz Limited
Company image
Address
Maxis 1, Western Road, Bracknell, RG12 1RF, UK
WWW
http://www.sandoz.uk.com
WWW
https://pvi1j.solutions.iqvia.com
Telephone
+44 (0) 1276 698020
Medical Information Direct Line
+44 (0)1276 698 101
Medical Information e-mail
[email protected]
Adverse event reporting email
[email protected]
Customer Care direct line
+44 (0)1276 698020
E-mail
[email protected]
E-mail
[email protected]